University Health Network

Toronto M5T 2S8

2 studies enrolling now · 10 studies all time

What they study most

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aneurysm, Brain, Antibody-mediated Rejection, Guillain-Barré Syndrome, Inherited Retinal Degeneration, Miller Fisher Syndrome, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia, Multifocal Motor Neuropathy (MMN), Myelodysplastic Syndromes

Studies at this site

• Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants — Recruiting now
• A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation — Recruiting now
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy — Running, not enrolling
• Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) — Completed
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities — Completed
• International Guillain-Barré Syndrome Outcome Study — Completed
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early
• Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia — Completed